AAAAAA
Results:
1-13
|
Results: 13
Authors:
Milella, M
Kornblau, SM
Estrov, Z
Carter, BZ
Lapillonne, H
Harris, D
Konopleva, M
Zhao, SR
Estey, E
Andreeff, M
Citation: M. Milella et al., Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia., J CLIN INV, 108(6), 2001, pp. 851-859
Authors:
Kornblau, SM
Stiouf, I
Snell, V
Przepiorka, D
Stephens, LC
Champlin, R
Marini, FC
Citation: Sm. Kornblau et al., Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes, CANCER RES, 61(8), 2001, pp. 3355-3360
Authors:
Giles, FJ
Kantarjian, HM
Kornblau, SM
Thomas, DA
Garcia-Manero, G
Waddelow, TA
David, CL
Phan, AT
Colburn, DE
Rashid, A
Estey, EH
Citation: Fj. Giles et al., Mylotarg(TM) (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation, CANCER, 92(2), 2001, pp. 406-413
Authors:
Tamm, I
Kornblau, SM
Segall, H
Krajewski, S
Welsh, K
Kitada, S
Scudiero, DA
Tudor, G
Qui, YH
Monks, A
Andreeff, M
Reed, JC
Citation: I. Tamm et al., Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias, CLIN CANC R, 6(5), 2000, pp. 1796-1803
Authors:
Kornblau, SM
Vu, HT
Ruvolo, P
Estrov, Z
O'Brien, S
Cortes, J
Kantarjian, H
Andreeff, M
May, WS
Citation: Sm. Kornblau et al., BAX and PKC alpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia, CLIN CANC R, 6(4), 2000, pp. 1401-1409
Authors:
Faderl, S
Kantarjian, HM
Estey, E
Manshouri, T
Chan, CY
Elsaied, AR
Kornblau, SM
Cortes, J
Thomas, DA
Pierce, S
Keating, MJ
Estrov, Z
Albitar, M
Citation: S. Faderl et al., The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia, CANCER, 89(9), 2000, pp. 1976-1982
Authors:
Kornblau, SM
Thall, PF
Estrov, Z
Walterscheid, M
Patel, S
Theriault, A
Keating, MJ
Kantarjian, H
Estey, E
Andreeff, M
Citation: Sm. Kornblau et al., The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics, CLIN CANC R, 5(7), 1999, pp. 1758-1766
Authors:
Faderl, S
Thall, PF
Kantarjian, HM
Talpaz, M
Harris, D
Van, Q
Beran, M
Kornblau, SM
Pierce, S
Estrov, Z
Citation: S. Faderl et al., Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia, CLIN CANC R, 5(12), 1999, pp. 4041-4047
Authors:
Kornblau, SM
Qiu, YH
Citation: Sm. Kornblau et Yh. Qiu, Altered expression of retinoblastoma (RB) protein in acute myelogenous leukemia does not result from methylation of the Rb promotor, LEUK LYMPH, 35(3-4), 1999, pp. 283-288
Authors:
Andreeff, M
Jiang, S
Zhang, X
Konopleva, M
Estrov, Z
Snell, VE
Xie, Z
Okcu, MF
Sanchez-Williams, G
Dong, J
Estey, EH
Champlin, RC
Kornblau, SM
Reed, JC
Zhao, S
Citation: M. Andreeff et al., Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid, LEUKEMIA, 13(11), 1999, pp. 1881-1892
Authors:
Marini, FC
Kornblau, SM
Citation: Fc. Marini et Sm. Kornblau, Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition, BONE MAR TR, 23(9), 1999, pp. 907-915
Authors:
Le, XF
Groner, Y
Kornblau, SM
Gu, Y
Hittelman, WN
Levanon, D
Mehta, K
Arlinghaus, RB
Chang, KS
Citation: Xf. Le et al., Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway, J BIOL CHEM, 274(31), 1999, pp. 21651-21658
Authors:
Konopleva, M
Mikhail, A
Estrov, Z
Zhao, SR
Harris, D
Sanchez-Williams, G
Kornblau, SM
Dong, J
Kliche, KO
Jiang, SW
Snodgrass, HR
Estey, EH
Andreeff, M
Citation: M. Konopleva et al., Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: Proliferative and anti-apoptotic activities, BLOOD, 93(5), 1999, pp. 1668-1676
Risultati:
1-13
|